Thomas Schinecker
Group Chief Executive OfficerDr. Thomas Schinecker serves as Chief Executive Officer at Roche Venture Fund. He is Chairman of the Board of Roche Holdings, Inc. from March 14, 2023. Dr. Schinecker is Director since March 27, 2025 at Chugai Pharmaceutical Co., Ltd. He serves as Chairman of the Board at Genentech, Inc. since March 2023. He is Group Chief Executive Officer of Roche Holding AG and served as its Chief Executive Officer since March 15, 2023. He has been Chief Executive Officer of Ventana Medical Systems, Inc. since August 1, 2019. Dr. Schinecker served as Global Head of Centralized and Point of Care Solutions at Roche Holding AG until August 1, 2019. 2003-2005. Roche Management Development Program “Perspectives”, Roche Singapore, Basel, Vienna and Mannheim. 2005-2008. Head of Marketing and Sales, Roche Diagnostics Austria, Vienna. 2008-2011. General Manager Roche Diagnostics, Sweden, Stockholm. 2011-2013. Lifecycle Leader Sequencing Solutions, Roche Diagnostics Branford and Madison. 2013-2017. General Manager of Roche Diagnostics Germany, Mannheim and Roche Holding Germany, Grenzach. Education: Genetics at University Salzburg, B.A., 1997. Molecular Biology at New York University, M.S., 2000. Doctorate in Molecular Biology at New York University, Ph.D., 2003.
Positions
- Company NameRoche Holding AGStock CodeRHHBYPositionGroup Chief Executive OfficerRelated SecuritiesColleagues
- SSSeverin SchwanExecutive Chairman
- AHAlan HippeChief Financial Officer
- WMWafaa MamilliChief Digital & Technology Officer
- BEBruno EschliHead of Investor Relations
- ASAndre S. HoffmannIndependent Vice Chairman
- JDJorg DuschmaleNon-Executive Independent Director
- PFPatrick FrostIndependent Non Executive Director
- RPRichard P. LiftonNon-Executive Independent Director
